April 18th 2017EP. 1: Nonvalvular Atrial Fibrillation and Risk of Stroke
April 18th 2017EP. 2: Differentiation of Direct Oral Anticoagulants for Nonvalvular Atrial Fibrillation
April 18th 2017EP. 3: Treatment With Direct Oral Anticoagulants for Nonvalvular Atrial Fibrillation
April 18th 2017EP. 4: Considerations With Direct Oral Anticoagulants for Nonvalvular Atrial Fibrillation
April 18th 2017EP. 5: Reversal Agents for Direct Oral Anticoagulants
April 18th 2017EP. 6: Anticoagulant Use to Prevent Stroke in Patients With NVAF
April 18th 2017EP. 7: Use of Warfarin in Nonvalvular Atrial Fibrillation
April 18th 2017EP. 8: Differentiation of Direct Oral Anticoagulants for NVAF
April 18th 2017EP. 9: Drug Monitoring and Reversal Agents for Direct Oral Anticoagulants
